4.1 Letter

Evolocumab for the treatment of heterozygous familial hypercholesterolemia in end-stage chronic kidney disease and dialysis

Journal

NEFROLOGIA
Volume 39, Issue 2, Pages 218-220

Publisher

SOC ESPANOLA NEFROLOGIA DR RAFAEL MATESANZ
DOI: 10.1016/j.nefro.2018.09.005

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available